We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
(-4%)
Cap. Flow
-$2.79B
Cap. Flow
% of AUM
-20.16%
Top 10 Holdings %
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$66.4M |
| 2 |
Valero Energy
VLO
|
+$28.9M |
| 3 |
SLB Ltd
SLB
|
+$24.8M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$22.6M |
| 5 |
PepsiCo
PEP
|
+$20.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$182M |
| 2 |
Apple
AAPL
|
+$148M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$90.9M |
| 4 |
Amgen
AMGN
|
+$72.1M |
| 5 |
Tesla
TSLA
|
+$66.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.26% |
| 2 | Technology | 28.78% |
| 3 | Financials | 8.15% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MPT
776
Medical Properties Trust
MPT
$2.89B
| – | – |
-33,685
| Closed | -$255K |
|
777
Match Group
MTCH
$8.84B
| – | – |
-30,008
| Closed | -$1.06M |
|
778
Vail Resorts
MTN
$5.19B
| – | – |
-2,512
| Closed | -$540K |
|
|
MTLS
779
Materialise
MTLS
$379M
| – | – |
-10,000
| Closed | -$76.4K |
|
780
Mitsubishi UFJ Financial
MUFG
$258B
| – | – |
-205,172
| Closed | -$1.21M |
|
781
NeoGenomics
NEO
$1.81B
| – | – |
-25,851
| Closed | -$414K |
|
782
National Health Investors
NHI
$3.9B
| – | – |
-5,000
| Closed | -$237K |
|
783
NIO
NIO
$11.3B
| – | – |
-130,000
| Closed | -$1.26M |
|
|
NVO
784
Novo Nordisk
NVO
$216B
| – | – |
-10
| Closed | -$3.8M |
|
785
Novartis
NVS
$295B
| – | – |
-27,767
| Closed | -$2.35M |
|
786
Newell Brands
NWL
$2.16B
| – | – |
-1,422,232
| Closed | -$16.3M |
|
787
News Corp Class A
NWSA
$14.5B
| – | – |
-50,339
| Closed | -$800K |
|
788
New York Times
NYT
$11.6B
| – | – |
-12,508
| Closed | -$448K |
|
789
Organon & Co
OGN
$3.55B
| – | – |
-20,486
| Closed | -$443K |
|
790
O-I Glass
OI
$1.39B
| – | – |
-561,385
| Closed | -$11.7M |
|
791
Omnicell
OMCL
$1.86B
| – | – |
-8,743
| Closed | -$472K |
|
|
ACH
792
Accendra Health
ACH
$240M
| – | – |
-33,879
| Closed | -$454K |
|
793
Option Care Health
OPCH
$3.4B
| – | – |
-17,620
| Closed | -$515K |
|
794
Ormat Technologies
ORA
$6.11B
| – | – |
-66,629
| Closed | -$5.2M |
|
795
Open Text
OTEX
$5.43B
| – | – |
-59,347
| Closed | -$2.1M |
|
|
PARA
796
DELISTED
Paramount Global Class B
PARA
| – | – |
-95,993
| Closed | -$1.97M |
|
797
Paylocity
PCTY
$6.71B
| – | – |
-2,352
| Closed | -$430K |
|
798
Vaxcyte
PCVX
$7.89B
| – | – |
-12,070
| Closed | -$416K |
|
799
Phathom Pharmaceuticals
PHAT
$912M
| – | – |
-63,778
| Closed | -$419K |
|
800
Plug Power
PLUG
$2.92B
| – | – |
-424,356
| Closed | -$4.58M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2023 Portfolio in Review
As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.
- Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
- Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
- Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
- Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
- Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
- Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
- Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.
Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.